These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28262147)

  • 1. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
    Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS
    Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
    Webber SK; Domniz Y; Sutton GL; Rogers CM; Lawless MA
    Cornea; 2001 Mar; 20(2):217-9. PubMed ID: 11248834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication.
    Rasmussen K; Kirk L; Faurbye A
    Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy.
    Razeghinejad MR; Nowroozzadeh MH; Zamani M; Amini N
    Clin Exp Ophthalmol; 2008 Aug; 36(6):560-3. PubMed ID: 18954320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorpromazine-induced refractile corneal deposits and cataract.
    Leung AT; Cheng AC; Chan WM; Lam DS
    Arch Ophthalmol; 1999 Dec; 117(12):1662-3. PubMed ID: 10604679
    [No Abstract]   [Full Text] [Related]  

  • 8. Total dosage of chlorpromazine and ocular opacities.
    Buffaloe WJ; Johnson AW; Sandifer MG
    Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587
    [No Abstract]   [Full Text] [Related]  

  • 9. A Case Report: Anti-Psychotic Agents Related Ocular Toxicity.
    Choy BNK; Ng ALK; Shum JWH; Fan MCY; Lai JSM
    Medicine (Baltimore); 2016 Apr; 95(15):e3360. PubMed ID: 27082594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpromazine-induced corneal toxicity.
    Koh V; Khor WB; Lim L
    Arch Ophthalmol; 2012 Nov; 130(11):1409. PubMed ID: 23143440
    [No Abstract]   [Full Text] [Related]  

  • 11. Cataract occurrence in patients treated with antipsychotic drugs.
    Souza VB; Moura Filho FJ; Souza FG; Rocha CF; Furtado FA; Gonçalves TB; Vasconcelos KF
    Braz J Psychiatry; 2008 Sep; 30(3):222-6. PubMed ID: 18833422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrimeprazine-induced corneal deposits and cataract revealed by urine drug profiling test.
    Kim ST; Koh JW; Kim JM; Kim WY; Choi GJ
    J Korean Med Sci; 2010 Nov; 25(11):1688-91. PubMed ID: 21060765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent chlorpromazine deposits in donor corneal tissue after corneal transplantation.
    Cahane M; Chen V; Avni I
    Cornea; 1997 Sep; 16(5):588-9. PubMed ID: 9294694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are schizophrenia or antipsychotic drugs a risk factor for cataracts?
    Ruigómez A; García Rodríguez LA; Dev VJ; Arellano F; Raniwala J
    Epidemiology; 2000 Nov; 11(6):620-3. PubMed ID: 11055620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenothiazine deposits in corneo and lens.
    Choong YY; Lim KS
    Med J Malaysia; 2001 Mar; 56(1):92-4. PubMed ID: 11503304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cataract occurrence with antipsychotic drugs.
    Shahzad S; Suleman MI; Shahab H; Mazour I; Kaur A; Rudzinskiy P; Lippmann S
    Psychosomatics; 2002; 43(5):354-9. PubMed ID: 12297603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module.
    Toshida H; Uesugi Y; Ebihara N; Murakami A
    Cornea; 2007 Oct; 26(9):1141-3. PubMed ID: 17893554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.